$2.35 Billion is the total value of Tekla Capital Management LLC's 143 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 19.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Sell | Gilead Sciences, Inc. | $181,183,000 | -13.9% | 2,530,131 | -4.9% | 7.72% | -4.6% |
| CELG | Sell | Celgene Corporation | $163,195,000 | +5.2% | 1,409,889 | -5.0% | 6.95% | +16.5% |
| BIIB | Buy | Biogen Inc. | $152,382,000 | +1.0% | 537,350 | +11.5% | 6.49% | +11.9% |
| ALXN | Buy | Alexion Pharmaceuticals, Inc. | $97,379,000 | +4.0% | 795,905 | +4.2% | 4.15% | +15.2% |
| AGN | Allergan plc | $91,162,000 | -8.8% | 434,086 | 0.0% | 3.88% | +1.0% | |
| INCY | Incyte Corporation | $88,284,000 | +6.3% | 880,461 | 0.0% | 3.76% | +17.8% | |
| VRTX | Vertex Pharmaceuticals Incorporated | $76,138,000 | -15.5% | 1,033,503 | 0.0% | 3.24% | -6.4% | |
| MRK | Sell | Merck & Co., Inc. | $70,547,000 | -9.3% | 1,198,349 | -3.9% | 3.00% | +0.5% |
| REGN | Buy | Regeneron Pharmaceuticals, Inc. | $68,890,000 | +11.1% | 187,666 | +21.7% | 2.94% | +23.1% |
| ABT | Buy | Abbott Laboratories | $60,830,000 | +4.3% | 1,583,700 | +14.9% | 2.59% | +15.6% |
| JNJ | Buy | Johnson & Johnson | $51,062,000 | +28.1% | 443,212 | +31.4% | 2.18% | +42.0% |
| BMRN | Sell | BioMarin Pharmaceutical Inc. | $47,438,000 | -27.8% | 572,645 | -19.4% | 2.02% | -20.0% |
| AMGN | Amgen Inc. | $47,027,000 | -12.3% | 321,640 | 0.0% | 2.00% | -2.9% | |
| MDT | Medtronic plcshares | $44,378,000 | -17.6% | 623,030 | 0.0% | 1.89% | -8.7% | |
| MYL | Mylan N.V.shares | $43,321,000 | +0.1% | 1,135,552 | 0.0% | 1.84% | +10.8% | |
| SHPG | Shire plcsponsored adr | $39,428,000 | -12.1% | 231,413 | 0.0% | 1.68% | -2.6% | |
| UNH | Sell | UnitedHealth Group Inc. | $39,357,000 | -15.1% | 245,920 | -25.7% | 1.68% | -5.9% |
| PFE | Pfizer Inc. | $37,244,000 | -4.1% | 1,146,689 | 0.0% | 1.59% | +6.2% | |
| LLY | Sell | Eli Lilly & Company | $36,268,000 | -36.7% | 493,100 | -30.9% | 1.54% | -29.9% |
| JAZZ | Jazz Pharmaceuticals plcshares | $36,134,000 | -10.2% | 331,411 | 0.0% | 1.54% | -0.6% | |
| HUM | Humana Inc. | $33,624,000 | +15.3% | 164,800 | 0.0% | 1.43% | +27.7% | |
| CVS | CVS Health Corporation | $32,502,000 | -11.3% | 411,891 | 0.0% | 1.38% | -1.8% | |
| ILMN | Illumina, Inc. | $31,570,000 | -29.5% | 246,560 | 0.0% | 1.34% | -21.9% | |
| TEVA | Teva Pharmaceutical Industries Ltd.sponsored adr | $28,600,000 | -21.2% | 788,958 | 0.0% | 1.22% | -12.8% | |
| MDCO | Buy | The Medicines Company | $26,189,000 | +22.9% | 771,638 | +36.7% | 1.12% | +36.3% |
| ABC | AmerisourceBergen Corporation | $25,856,000 | -3.2% | 330,687 | 0.0% | 1.10% | +7.2% | |
| CNC | Buy | Centene Corporation | $22,604,000 | +31.6% | 400,000 | +55.9% | 0.96% | +45.9% |
| MOH | Molina Healthcare, Inc. | $21,842,000 | -7.0% | 402,541 | 0.0% | 0.93% | +3.0% | |
| TMO | Buy | Thermo Fisher Scientific Inc. | $19,912,000 | +44.9% | 141,120 | +63.3% | 0.85% | +60.6% |
| NVS | Novartis AGsponsored adr | $18,123,000 | -7.7% | 248,800 | 0.0% | 0.77% | +2.3% | |
| UHS | Buy | Universal Health Services, Inc.class b | $15,614,000 | -5.9% | 146,780 | +9.0% | 0.66% | +4.2% |
| IDXX | IDEXX Laboratories, Inc. | $15,521,000 | +4.0% | 132,352 | 0.0% | 0.66% | +15.2% | |
| IBB | iShares Nasdaq Biotechnology ETFetf | $15,304,000 | -8.3% | 57,670 | 0.0% | 0.65% | +1.6% | |
| NBIX | Sell | Neurocrine Biosciences, Inc. | $15,165,000 | -54.4% | 391,869 | -40.3% | 0.65% | -49.5% |
| ENDP | Endo International plcshares | $15,063,000 | -18.3% | 914,548 | 0.0% | 0.64% | -9.4% | |
| OHI | Buy | Omega Healthcare Investors, Inc. | $14,336,000 | -2.1% | 458,616 | +11.0% | 0.61% | +8.5% |
| HCA | Buy | HCA Holdings, Inc. | $14,081,000 | +94.6% | 190,232 | +98.8% | 0.60% | +115.8% |
| GSK | GlaxoSmithKline plcsponsored adr | $13,825,000 | -10.7% | 359,000 | 0.0% | 0.59% | -1.0% | |
| SBRA | Buy | Sabra Health Care REIT, Inc. | $13,455,000 | +17.1% | 550,990 | +20.8% | 0.57% | +29.6% |
| UTHR | United Therapeutics Corporation | $13,353,000 | +21.5% | 93,100 | 0.0% | 0.57% | +34.5% | |
| SRPT | Buy | Sarepta Therapeutics, Inc. | $12,791,000 | -2.7% | 466,300 | +117.8% | 0.54% | +7.7% |
| AZN | AstraZeneca PLCsponsored adr | $12,671,000 | -16.9% | 463,800 | 0.0% | 0.54% | -7.8% | |
| MPW | Buy | Medical Properties Trust, Inc. | $12,395,000 | 0.0% | 1,007,717 | +20.1% | 0.53% | +10.7% |
| SNY | Sanofisponsored adr | $12,334,000 | +5.9% | 305,000 | 0.0% | 0.52% | +17.2% | |
| SNH | Buy | Senior Housing Properties Trustshares | $12,239,000 | -6.3% | 646,554 | +12.4% | 0.52% | +3.8% |
| WELLPRI | Welltower Inc.6.50% preferred perpetual | $12,036,000 | -9.6% | 200,000 | 0.0% | 0.51% | +0.2% | |
| PRTK | Paratek Pharmaceuticals, Inc. | $11,744,000 | +18.4% | 762,581 | 0.0% | 0.50% | +30.9% | |
| CI | Cigna Corporation | $11,525,000 | +2.4% | 86,400 | 0.0% | 0.49% | +13.4% | |
| VTR | Buy | Ventas, Inc. | $11,003,000 | +2.2% | 175,991 | +15.4% | 0.47% | +13.3% |
| CAH | Cardinal Health, Inc. | $10,975,000 | -7.4% | 152,500 | 0.0% | 0.47% | +2.6% | |
| XBI | New | SPDR S&P Biotech ETFetf | $10,595,000 | – | 179,000 | +100.0% | 0.45% | – |
| ZBH | Zimmer Biomet Holdings, Inc. | $10,557,000 | -20.6% | 102,300 | 0.0% | 0.45% | -11.9% | |
| BDX | Becton, Dickinson and Co. | $10,443,000 | -7.9% | 63,078 | 0.0% | 0.44% | +2.1% | |
| NTRA | Natera, Inc. | $10,332,000 | +5.4% | 882,358 | 0.0% | 0.44% | +16.7% | |
| FOMX | Sell | Foamix Pharmaceuticals Ltdshares | $10,327,000 | +15.4% | 930,398 | -3.7% | 0.44% | +27.9% |
| MRUS | Buy | Merus B.V. | $10,115,000 | +132.3% | 479,150 | +84.3% | 0.43% | +158.1% |
| DOC | Physicians Realty Trust | $10,062,000 | -12.0% | 530,672 | 0.0% | 0.43% | -2.5% | |
| CRL | Buy | Charles River Laboratories International, Inc. | $9,722,000 | +1.4% | 127,600 | +11.0% | 0.41% | +12.2% |
| Aegerion Pharmaceuticals, Inc.note 2.00% 5/15/19 | $9,263,000 | +8.1% | 13,000,000 | 0.0% | 0.40% | +19.7% | ||
| ALNY | Alnylam Pharmaceuticals, Inc. | $9,135,000 | -44.8% | 243,995 | 0.0% | 0.39% | -38.8% | |
| ARDX | Sell | Ardelyx, Inc. | $9,079,000 | -0.9% | 639,370 | -9.6% | 0.39% | +9.9% |
| CCP | New | Care Capital Properties, Inc. | $8,626,000 | – | 345,022 | +100.0% | 0.37% | – |
| CTMX | CytomX Therapeutics, Inc. | $8,309,000 | -29.9% | 756,090 | 0.0% | 0.35% | -22.4% | |
| EXEL | Exelixis, Inc. | $8,225,000 | +16.6% | 551,647 | 0.0% | 0.35% | +29.2% | |
| PBYI | Puma Biotechnology, Inc. | $7,988,000 | -54.2% | 260,200 | 0.0% | 0.34% | -49.3% | |
| GLPG | Sell | Galapagos NVsponsored adr | $7,429,000 | -22.2% | 115,738 | -21.7% | 0.32% | -13.9% |
| AKRXQ | Buy | Akorn, Inc. | $7,154,000 | +80.7% | 327,735 | +125.7% | 0.30% | +100.7% |
| FLML | Flamel Technologies SAsponsored adr | $6,486,000 | -16.2% | 624,288 | 0.0% | 0.28% | -7.4% | |
| LTC | Buy | LTC Properties, Inc. | $6,399,000 | +15.9% | 136,212 | +28.2% | 0.27% | +28.8% |
| RARE | Ultragenyx Pharmaceutical Inc. | $6,215,000 | -0.9% | 88,400 | 0.0% | 0.26% | +10.0% | |
| Egalet Corporationnote 5.50% 4/1/20 | $6,059,000 | +1.6% | 7,000,000 | 0.0% | 0.26% | +12.7% | ||
| PIRS | Pieris Pharmaceuticals, Inc. | $5,804,000 | -23.5% | 4,145,958 | 0.0% | 0.25% | -15.4% | |
| PRAH | PRA Health Sciences, Inc. | $5,622,000 | -2.5% | 102,000 | 0.0% | 0.24% | +7.7% | |
| SNR | Buy | New Senior Investment Group Inc. | $5,561,000 | +11.8% | 567,997 | +31.8% | 0.24% | +24.1% |
| GBT | Buy | Global Blood Therapeutics, Inc. | $5,510,000 | +91.3% | 381,300 | +205.0% | 0.24% | +111.7% |
| ICLR | ICON plcshares | $5,414,000 | -2.8% | 72,000 | 0.0% | 0.23% | +7.9% | |
| XENE | Xenon Pharmaceuticals Inc. | $5,390,000 | -4.9% | 700,000 | 0.0% | 0.23% | +5.5% | |
| CLLS | Cellectis S.A.sponsored adr | $5,259,000 | -29.6% | 310,250 | 0.0% | 0.22% | -22.0% | |
| DERM | Buy | Dermira, Inc. | $5,011,000 | +79.3% | 165,200 | +100.0% | 0.21% | +99.1% |
| MYOV | New | Myovant Sciences Ltd. | $4,976,000 | – | 400,000 | +100.0% | 0.21% | – |
| EPZM | Epizyme, Inc. | $4,840,000 | +23.0% | 400,000 | 0.0% | 0.21% | +36.4% | |
| KPTI | Karyopharm Therapeutics Inc. | $4,703,000 | -3.4% | 500,324 | 0.0% | 0.20% | +7.0% | |
| MNTA | Buy | Momenta Pharmaceuticals, Inc. | $4,614,000 | +156.8% | 306,600 | +99.5% | 0.20% | +185.5% |
| Immunomedics, Inc.note 4.75% 2/15/20 | $3,960,000 | +17.2% | 4,000,000 | 0.0% | 0.17% | +30.0% | ||
| AGNPRA | Allergan plcpreferred convertible | $3,812,000 | -7.2% | 5,000 | 0.0% | 0.16% | +2.5% | |
| BGNE | BeiGene, Ltd.sponsored adr | $3,543,000 | -1.5% | 116,707 | 0.0% | 0.15% | +9.4% | |
| ACAD | ACADIA Pharmaceuticals Inc. | $3,224,000 | -9.3% | 111,800 | 0.0% | 0.14% | 0.0% | |
| RTRX | Sell | Retrophin, Inc. | $3,179,000 | -56.9% | 167,949 | -49.1% | 0.14% | -52.5% |
| PRGO | Perrigo Company plcshares | $3,104,000 | -9.9% | 37,300 | 0.0% | 0.13% | 0.0% | |
| MNKKQ | Mallinckrodt plcshares | $3,084,000 | -28.6% | 61,900 | 0.0% | 0.13% | -21.1% | |
| BLUE | bluebird bio, Inc. | $3,045,000 | -9.0% | 49,345 | 0.0% | 0.13% | +0.8% | |
| VRX | Valeant Pharmaceuticals International, Inc. | $2,788,000 | -40.9% | 192,000 | 0.0% | 0.12% | -34.3% | |
| SAGE | Sell | Sage Therapeutics, Inc. | $2,757,000 | -59.2% | 54,000 | -63.2% | 0.12% | -55.0% |
| GRFS | Grifols, S.A.sponsored adr | $2,668,000 | +0.6% | 166,000 | 0.0% | 0.11% | +11.8% | |
| HZNP | Sell | Horizon Pharma plcshares | $2,636,000 | -80.6% | 162,900 | -78.3% | 0.11% | -78.6% |
| CHRS | New | Coherus Biosciences, Inc. | $2,534,000 | – | 90,000 | +100.0% | 0.11% | – |
| AXDX | Accelerate Diagnostics, Inc. | $2,490,000 | -23.9% | 120,000 | 0.0% | 0.11% | -15.9% | |
| THC | Tenet Healthcare Corporation | $2,441,000 | -34.5% | 164,500 | 0.0% | 0.10% | -27.3% | |
| ABIO | ARCA biopharma, Inc. | $2,312,000 | -1.4% | 811,227 | 0.0% | 0.10% | +8.9% | |
| ADAP | Adaptimmune Therapeutics plcsponsored adr | $2,294,000 | -42.5% | 566,368 | 0.0% | 0.10% | -36.4% | |
| DBVT | DBV Technologies S.A.sponsored adr | $2,305,000 | -3.3% | 65,600 | 0.0% | 0.10% | +6.5% | |
| ELGX | Sell | Endologix, Inc. | $2,212,000 | -77.7% | 386,750 | -50.0% | 0.09% | -75.3% |
| ACHC | Buy | Acadia Healthcare Company, Inc. | $2,148,000 | +23.2% | 64,900 | +84.4% | 0.09% | +37.3% |
| ADMS | New | Adamas Pharmaceuticals, Inc. | $2,121,000 | – | 125,504 | +100.0% | 0.09% | – |
| MCK | McKesson Corporation | $2,107,000 | -15.8% | 15,000 | 0.0% | 0.09% | -6.2% | |
| FOLD | Buy | Amicus Therapeutics, Inc. | $2,081,000 | +9.0% | 418,730 | +62.3% | 0.09% | +21.9% |
| NBRV | New | Nabriva Therapeutics AGsponsored adr | $2,083,000 | – | 350,000 | +100.0% | 0.09% | – |
| HR | New | Healthcare Realty Trust, Inc. | $2,062,000 | – | 68,000 | +100.0% | 0.09% | – |
| FWP | Forward Pharma A/Ssponsored adr | $2,050,000 | -28.5% | 136,547 | 0.0% | 0.09% | -20.9% | |
| HALO | Halozyme Therapeutics, Inc. | $1,976,000 | -18.2% | 200,000 | 0.0% | 0.08% | -9.7% | |
| ACHN | New | Achillion Pharmaceuticals, Inc. | $1,833,000 | – | 443,851 | +100.0% | 0.08% | – |
| MDRX | Allscripts Healthcare Solutions, Inc. | $1,772,000 | -22.5% | 173,600 | 0.0% | 0.08% | -14.8% | |
| DPLO | Buy | Diplomat Pharmacy, Inc. | $1,641,000 | -32.8% | 130,223 | +49.4% | 0.07% | -25.5% |
| IPXL | Impax Laboratories, Inc. | $1,647,000 | -44.1% | 124,335 | 0.0% | 0.07% | -38.1% | |
| CMRX | Chimerix, Inc. | $1,421,000 | -16.9% | 308,892 | 0.0% | 0.06% | -7.6% | |
| WELL | New | Welltower Inc. | $1,432,000 | – | 21,400 | +100.0% | 0.06% | – |
| CDTX | Cidara Therapeutics, Inc. | $1,378,000 | -9.2% | 132,472 | 0.0% | 0.06% | +1.7% | |
| XLRN | New | Acceleron Pharma, Inc. | $1,390,000 | – | 54,450 | +100.0% | 0.06% | – |
| DVAX | Dynavax Technologies Corporation | $1,363,000 | -62.3% | 345,050 | 0.0% | 0.06% | -58.3% | |
| HCP | New | HCP, Inc. | $1,352,000 | – | 45,500 | +100.0% | 0.06% | – |
| QURE | uniQure N.V.shares | $1,350,000 | -26.8% | 241,021 | 0.0% | 0.06% | -18.3% | |
| HTA | New | Healthcare Trust of America, Inc.class a | $1,339,000 | – | 46,000 | +100.0% | 0.06% | – |
| ESPR | Esperion Therapeutics, Inc. | $1,287,000 | -9.6% | 102,800 | 0.0% | 0.06% | 0.0% | |
| ONCE | New | Spark Therapeutics, Inc. | $1,213,000 | – | 24,300 | +100.0% | 0.05% | – |
| GNMK | GenMark Diagnostics, Inc. | $1,143,000 | +3.7% | 93,349 | 0.0% | 0.05% | +16.7% | |
| CYH | Sell | Community Health Systems, Inc. | $1,140,000 | -67.6% | 203,935 | -33.0% | 0.05% | -63.7% |
| TXMD | Sell | TherapeuticsMD, Inc. | $1,080,000 | -48.4% | 187,100 | -39.1% | 0.05% | -42.5% |
| JUNO | Sell | Juno Therapeutics, Inc. | $1,073,000 | -80.4% | 56,900 | -68.7% | 0.05% | -78.1% |
| ALQA | Alliqua BioMedical, Inc. | $974,000 | -24.3% | 1,650,000 | 0.0% | 0.04% | -16.3% | |
| NTLA | Intellia Therapeutics, Inc. | $942,000 | -23.0% | 71,842 | 0.0% | 0.04% | -14.9% | |
| FLKS | Flex Pharma, Inc. | $856,000 | -55.2% | 162,124 | 0.0% | 0.04% | -50.7% | |
| BLCM | Bellicum Pharmaceuticals, Inc. | $817,000 | -31.6% | 60,000 | 0.0% | 0.04% | -23.9% | |
| EARS | Auris Medical Holding AG | $829,000 | -38.1% | 774,504 | 0.0% | 0.04% | -32.7% | |
| TTPH | Tetraphase Pharmaceuticals, Inc. | $775,000 | +5.2% | 192,322 | 0.0% | 0.03% | +17.9% | |
| NVAX | Novavax, Inc. | $719,000 | -39.5% | 571,000 | 0.0% | 0.03% | -32.6% | |
| GMRE | New | Global Medical REIT Inc. | $655,000 | – | 73,400 | +100.0% | 0.03% | – |
| AFMD | Affimed NV | $530,000 | -35.2% | 294,213 | 0.0% | 0.02% | -25.8% | |
| XNCR | Xencor, Inc. | $526,000 | +7.3% | 20,000 | 0.0% | 0.02% | +15.8% | |
| CLDX | Celldex Therapeutics, Inc. | $375,000 | -12.2% | 105,800 | 0.0% | 0.02% | 0.0% | |
| RMR | The RMR Group Inc.class a | $294,000 | +4.3% | 7,441 | 0.0% | 0.01% | +18.2% | |
| QHCCQ | Sell | Quorum Health Corporation | $172,000 | -63.9% | 23,725 | -68.8% | 0.01% | -61.1% |
| ZFGN | Zafgen, Inc. | $42,000 | -4.5% | 13,307 | 0.0% | 0.00% | 0.0% | |
| ABBV | AbbVie Inc. | $10,000 | 0.0% | 156 | 0.0% | 0.00% | – | |
| RVNC | Exit | Revance Therapeutics, Inc. | $0 | – | -75,000 | -100.0% | -0.05% | – |
| ITEK | Exit | Inotek Pharmaceuticals Corporation | $0 | – | -180,762 | -100.0% | -0.07% | – |
| MACK | Exit | Merrimack Pharmaceuticals, Inc. | $0 | – | -286,000 | -100.0% | -0.07% | – |
| Exit | Merrimack Pharmaceuticals, Inc.note 4.50% 7/15/20 | $0 | – | -1,485,000 | -100.0% | -0.07% | – | |
| NVRO | Exit | Nevro Corp. | $0 | – | -25,000 | -100.0% | -0.10% | – |
| DEPO | Exit | Depomed, Inc. | $0 | – | -200,000 | -100.0% | -0.19% | – |
| VTAE | Exit | Vitae Pharmaceuticals, Inc. | $0 | – | -250,000 | -100.0% | -0.20% | – |
| ARIA | Exit | ARIAD Pharmaceuticals, Inc. | $0 | – | -502,000 | -100.0% | -0.26% | – |
| Exit | Supernus Pharmaceuticals, Inc.note 7.50% 5/1/19 | $0 | – | -2,000,000 | -100.0% | -0.36% | – | |
| DVA | Exit | DaVita, Inc. | $0 | – | -161,100 | -100.0% | -0.41% | – |
| CPHD | Exit | Cepheid, Inc. | $0 | – | -333,590 | -100.0% | -0.68% | – |
| A | Exit | Agilent Technologies, Inc. | $0 | – | -459,950 | -100.0% | -0.83% | – |
| ALKS | Exit | Alkermes plcshares | $0 | – | -581,944 | -100.0% | -1.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.